Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Saved in:
| Title: | Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer. |
|---|---|
| Authors: | Knox JJ, O'Kane G, King D, Laheru D, Habowski AN, Yu K, Perez K, Aguirre AJ, Coyne Z, Harvey H, McLaughlin RA, Jang RW, Grant RC, Elimova EC, Renouf DJ, Fischer S, Duan K, Ramotar S, Jang GH, Zhang A, Devoe CE, Singh H, Pishvaian MJ, Froeling FEM, Saif MW, O'Reilly EM, Tsang ES, Wolpin BM, Wilson JM, Dodd A, Pugh TJ, Ye XY, Gallinger S, Tuveson DA, Notta F, Jaffee EM |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Oct 20; Vol. 43 (30), pp. 3325. Date of Electronic Publication: 2025 Sep 24. |
| Publication Type: | Journal Article; Published Erratum |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
